The underlying mechanism related to miR-26a may be suppression of HCC cell proliferation and metastasis by regulation of the IL-6-stat3 signaling pathway and inhibition of angiogenesis in HCC by down-regulating Akt/VEGF signaling [27, 47, 48]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.